NT,
I am a long sufferring shareholder who has watched this management team treat the company as their own without putting their own money in. Salaries are way out of line with industry practice.
I have always believed in the science. The drug is good and I am confident a deal will be done with or without the chairman. I am simply not happy at the shareholder wealth destroyed over the years by an inexperienced (pharma) chairman. You just have to look what he has done to ATIF shareholders.
I would be interested in which directors plan to put their hand in their pocket for this raising, and for how much?
Ann: 249D Notice Update , page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)